APTENSIO XR 40 MG CAPSULE

methylphenidate hydrochloride
$7.9434per EA
DEA Schedule CII

Strength

40 mg/1

NDC

42858040545

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

2/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA205831

On Market Since

4/17/2015

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.1%

1Y

-0.1%

3Y

-0.7%

5Y

-0.7%

All

+14.9%